Back to results
US 2021/0267906 A1Published application
Novel amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide
AssigneeSun Pharma Advanced Research Company Ltd.
InventorsYashoraj ZALA, Bramhanand HANAMANNAVAR, Nitin DHARMADHIKARI
Life of this patent
Estimating the term…
Abstract
An oral solid dosage form comprising a mixture of compound of formula I and a fusible polymeric carrier; and optionally pharmaceutically acceptable excipients, wherein the mixture is an amorphous dispersion.
Claims28
A method of treating a disease treatable by the inhibition of ABL tyrosine kinase comprising administering an oral, solid dosage form of a compound of Formula I to a human,
- wherein the compound of Formula I is non-crystalline
Dependencies are inferred from the claim text.